Lead party: Azur Innovation Management (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Blink Pharma
Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity · Instrument: Equity · Round: Seed · Fund: Azur Innovation Fund
Lead investor/buyer: Azur Innovation Management · Investors/buyers: Azur Innovation Management
Legal advisers: not identified in the source record.
Source: announced 23 May 2022. Original announcement: wamda.com.


